drugset / Trial / NCT01518231
Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of autologous peripheral hematopoietic stem cell transplantation in ischemic stroke.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 100 mg | Oral |
| Comparator | Atorvastatin | Small molecule | 20 mg | Oral |
| Comparator | Edaravone | Unknown | 30 mg | Intravenous |
| Comparator | Warfarin | Small molecule | 2 mg | Oral |
| Comparator | Warfarin | Small molecule | 6 mg | Oral |